chcuk@syneoshealth.com
  • Home
  • Contact
CHCUK
  • NIS
    • NIS Definitions
    • Study Classification
    • NIS Training Solutions
    • NIS Country-Specific Reports
    • NIS Regulatory Database
    • NIS Regulatory Consulting
    • NIS Resources & Useful Links
    • RWR Glossary
  • PCTs
    • PCT Definitions
    • PCT Regulatory Consulting
    • PCT Useful Links
    • RWR Glossary
  • GCP
    • GCP Definitions
    • GCP Useful Links
    • RWR Glossary
  • News
  • About
  • Contact
Select Page
NICE Consultation – Consideration of RWD/RWE to Drive Decisions

NICE Consultation – Consideration of RWD/RWE to Drive Decisions

by Syneos Health_1 | 18 Jul, 2019 | Consultation, Real Word Evidence, RWD

Summary NICE welcomes the opportunity to continue our well-established practice of translating evidence into practical guidance and advice, and to expand our methods and processes to enable more extensive and effective use of broader sources of data. We acknowledge...

The Good, the Bad and the Unresolved: Proposed Changes to the UK Market Access for Medicines

by chuck_ltd | 18 Jan, 2017 | Brexit, CHCUK News & Articles, Market Access, News

In October 2016, the National institute for Health and Care Excellence (NICE) and National Health Service England (NHS England) launched a 12 week consultation on proposed changes to the arrangements for evaluating and funding drugs and other health technologies...

NICE Approves Minimally Invasive Laser Therapy for Benign Prostate Disease

by chuck_ltd | 16 Jun, 2016 | CHCUK News & Articles, News

Most men aged over 60 have some form of enlargement of the prostate gland and around 13,000 men in the UK are thought to have non-cancerous enlargement known as benign prostatic hypertrophy (BPH). This condition can make it difficult to pass urine as the swollen...

New Government Guidelines Introduced to Reduce Premature Birth Rates

by chuck_ltd | 24 Dec, 2015 | CHCUK News & Articles, News, NIS, Professional Standards

The National Institute for Health and Care Excellence (NICE) has published a new guideline that aims to reduce the rate of premature births in the UK. Each year, 60,000 babies are born prematurely in the UK.  Sadly, the reality is that some of these babies will not...

Categories

  • 21 Century Cures Act
  • 3D Printers
  • AI
  • Biological Products
  • Biosamples
  • Biosimilars
  • Brexit
  • CHCUK News & Articles
  • CHCUK NIS Database
  • Consultation
  • Cures Act
  • Cybersecurity
  • Data Integrity
  • Data Privacy
  • Digital Health Technology
  • EAP
  • eConsent
  • EFPIA
  • EHR
  • eletronic Signatures
  • EMA
  • EU Clinical Trials Regulation
  • FDA 1572
  • FDA Guidance
  • FDAMA114
  • GCP
  • GCP Inspections
  • GDPR
  • Genetic Research
  • GVP
  • HIPAA
  • HTA
  • Human Tissue Research
  • Immunological Products
  • Informed Consent
  • Market Access
  • Medical Apps
  • Medical Devices
  • News
  • NIS
  • NIS Considerations Report
  • Orphan Drugs
  • PASS
  • Patient Centricity
  • Pragmatic Trials
  • Professional Standards
  • Promotion and Advertising
  • PROs
  • Publication Guidelines
  • Rare Diseases
  • Real Word Evidence
  • Real World Evidence
  • Real World Research Design
  • Registry
  • Regulatory Grade RWE
  • Regulatory Intelligence
  • Regulatory Science
  • Reimbursement
  • RWD
  • Safety Management
  • Sunshine Regulations
  • Transparency
  • Uncategorized
  • Virtual Clinical Research
  • Webinar
  • White Paper

News

December 2023
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Feb    

Legal Information:

  • Terms & Conditions
  • Disclaimer
  • Privacy Notice

• CHCUK NIS Regulatory Database
• Contact CHCUK

  • Facebook
  • X
Copyright © 2023 CHCUK. All Rights Reserved.

design by Poppy Design